NeuBase Therapeutics, Inc. (NBSE)
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 1.57M |
| Enterprise Value | -5.67M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.17 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.20 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.96 |
| 52-Week Change 3 | -85.11% |
| S&P500 52-Week Change 3 | 24.19% |
| 52 Week High 3 | 4.8000 |
| 52 Week Low 3 | 0.3900 |
| 50-Day Moving Average 3 | 0.6691 |
| 200-Day Moving Average 3 | 0.7825 |
Share Statistics
| Avg Vol (3 month) 3 | 238.73k |
| Avg Vol (10 day) 3 | 58.06k |
| Shares Outstanding 5 | 3.75M |
| Implied Shares Outstanding 6 | 3.94M |
| Float 8 | 3.3M |
| % Held by Insiders 1 | 13.38% |
| % Held by Institutions 1 | 12.69% |
| Shares Short (Apr 15, 2024) 4 | 24.46k |
| Short Ratio (Apr 15, 2024) 4 | 0.11 |
| Short % of Float (Apr 15, 2024) 4 | 0.70% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 0.65% |
| Shares Short (prior month Mar 15, 2024) 4 | 80.45k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Feb 04, 2019 |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:20 |
| Last Split Date 3 | Jun 15, 2023 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Sept 30, 2022 |
| Most Recent Quarter (mrq) | Sept 30, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | 0.00% |
Management Effectiveness
| Return on Assets (ttm) | -43.03% |
| Return on Equity (ttm) | -93.46% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -23.41M |
| Net Income Avi to Common (ttm) | -24.59M |
| Diluted EPS (ttm) | -18.6000 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 12.57M |
| Total Cash Per Share (mrq) | 3.37 |
| Total Debt (mrq) | 5.34M |
| Total Debt/Equity (mrq) | 58.39% |
| Current Ratio (mrq) | 7.40 |
| Book Value Per Share (mrq) | 2.45 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -24.69M |
| Levered Free Cash Flow (ttm) | -15.18M |
© 2024 Yahoo. All rights reserved.